58 results
424B8
NMRD
Nemaura Medical Inc
11 Sep 23
Prospectus unintentially filed late
4:41pm
announced that we had been awarded CE approval to allow sugarBEAT® to be legally sold in the European Union. CE approval is disclosed by the use of the CE … to achieve a mandatory conformity marking for the sugarBEAT® device to allow it to be legally sold in the European Union. It is a manufacturers
POS AM
NMRD
Nemaura Medical Inc
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
29, 2019, we announced that we had been awarded CE approval to allow sugarBEAT® to be legally sold in the European Union. CE approval is disclosed … is the process to achieve a mandatory conformity marking for the sugarBEAT® device to allow it to be legally sold in the European Union
424B4
NMRD
Nemaura Medical Inc
15 May 23
Prospectus supplement with pricing info
4:31pm
be required.
Each year, millions of patients undergo diabetes testing in the European Union and in the U.S. The main reason for this testing is to detect … and Wales and the European Union regulations
Government authorities in the United Kingdom and Wales and the European Union as well as other foreign
CORRESP
2xvs6prnt4jrk
10 May 23
Correspondence with SEC
12:00am
424B5
vmeegb6h
1 Apr 22
Prospectus supplement for primary offering
4:29pm
8-K
EX-10.1
h7euyw
30 Sep 21
Entry into a Material Definitive Agreement
4:44pm
424B5
rxshsvuur4agr1zku2
23 Jul 21
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
e4vojxq4kfyfbwzjo
23 Jul 21
Entry into a Material Definitive Agreement
4:22pm